There is a very high prevalence of cigarette smoking among people with serious mental illness. Dr. Tidey's research focuses on biological, environmental and social factors that influence cigarette smoking in people with schizophrenia. She also studies medications and behavioral treatments, particularly contingency management, for tobacco and alcohol dependence in adults and adolescents.

Biography

Brief Bio

Dr. Tidey is an Associate Professor of Psychiatry and Human Behavior (Research), a faculty member in the Center for Alcohol and Addiction Studies and the Director of the Center's Addictive Behaviors Research Laboratory. She received her PhD in Experimental Psychology, specializing in psychopharmacology, from Tufts University in 1995. She was a postdoctoral fellow in the Center's NIAAA-funded training program in 1999-2000. In her research she uses laboratory and clinical studies to develop more effective treatments for cigarette smoking and other addictive disorders in people with serious mental illness.

Institutions

Bh

Research Description

Jennifer Tidey's research focuses primarily on testing medications and behavioral strategies for reducing cigarette smoking among people with serious mental illness. She is a Research Component Principal Investigator of a NIDA-funded P50 Center grant entitled "Evaluating New Nicotine Standards for Cigarettes" (Eric Donny, Dorothy Hatsukami, Co-PIs). Dr. Tidey's component, entitled "Very Low Nicotine Cigarettes in Smokers with Schizophrenia", investigates a novel public health strategy for reducing smoking among people with schizophrenia. She is also a co-investigator and site Principal Investigator of a project that will compare, in non-psychiatric smokers, the behavioral, biological and subjective effects of cigarettes varying in nicotine and tar contents. In addition, she is a co-investigator or other significant contributor on 10 NIH-funded grants that test pharmacological and behavioral treatments for tobacco or alcohol dependence in adults and adolescents. She also serves as an advisor on several NIH-funded training awards.

Awards

Masters of Arts ad eundem (honorary degree), Brown University, Providence, RI, 2010
Early Career Investigator Award, College on Problems of Drug Dependence, 1997
Senator Proctor Research Award, American Lung Association of Vermont, 1998
Director's Travel Award, National Institute on Drug Abuse (NIDA), 1999
Research Excellence Award, Center for Alcohol and Addiction Studies, Brown University, 2000, 2002, 2007
Memorial Travel Fellow, American College of Neuropsychopharmacology (ACNP), 2002
Service Award, Society for Research on Nicotine and Tobacco (SRNT), 2006

Affiliations

College on Problems of Drug Dependence (CPDD), 2002 – present
--CPDD Human Research Committee 2010 - present
--CPDD Program Committee 2007 - 2010
--CPDD Travel Awards and Mentoring Committee, 2002 – 2007

Society for Research on Nicotine and Tobacco (SRNT), 2000 – present
--SRNT Conference Program Co-Chair, 2005-2006
Behavioral Pharmacology Society, 1992 – present
International Study Group Investigating Drugs as Reinforcers, 1996 – present
Research Society on Alcoholism, 2001 – present

Funded Research

CURRENT GRANT SUPPORT
1. "Evaluating New Nicotine Standards for Cigarettes", Eric Donny, Ph.D., Dorothy Hatsukami, Ph.D., Co-Principal Investigators
Grant type/number: P50 DA031659-01
Funding agency: National Institute on Drug Abuse
Project 1: "Human Laboratory Evaluation of Very Low Nicotine Cigarettes"
Period: September 2011 – February 2013
Project direct costs: $329,140; Project total costs: $533,205
Role: Project 1 Co-Investigator/Site Principal Investigator

2. "Evaluating New Nicotine Standards for Cigarettes", Eric Donny, Ph.D., Dorothy Hatsukami, Ph.D., Co-Principal Investigators
Grant type/number: P50 DA031659-01
Funding agency: National Institute on Drug Abuse
Project 3: "Very Low Nicotine Cigarettes in Smokers with Schizophrenia"
Period: March 2013 – August 2016
Project direct costs: $777,942; Project total costs: $1,260,267
Role: Project 3 Principal Investigator

3. "Smoking Abstinence and Lapse Effects in Smokers with Schizophrenia and Controls"
Grant type/number: R21 DA026829-02
Funding agency: National Institute on Drug Abuse
Period: June 2009 – May 2012
Project direct costs: $275,000; Project total costs: $444,750
Role: Principal Investigator

4. "Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms"
Principal Investigator: Robert Miranda, Jr., Ph.D.
Grant type/number: R01 AA007850-21
Funding agency: National Institute on Alcohol Abuse and Alcoholism
Period: September 2011 – August 2016
Project direct costs: $2,102,535; Project total costs: $3,405,597
Role: Co-Investigator

5. "Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents"
Principal Investigator: Robert Miranda, Jr., Ph.D.
Grant type/number: R01 DA026778-02
Funding agency: National Institute on Drug Abuse
Period: June 2009 – May 2012
Project direct costs: $691,094; Project total costs: $1,117,259
Role: Co-Investigator

6. "Biobehavioral Mechanisms of Topiramate and Drinking"
Principal Investigator: Peter M. Monti, Ph.D.
Grant type/number: R01 AA007850-20
Funding agency: National Institute on Alcohol Abuse and Alcoholism
Period: January 2006 – December 2011
Project direct costs: $2,043,580; Project total costs: $3,076,890
Role: Co-Investigator

7. "Motivation and Skills for Detained Teen Smokers"
Principal Investigator: Lynda Stein, Ph.D.
Grant type/number: R01 DA020731-03
Funding agency: National Institute on Drug Abuse
Period: September 2007 – June 2012
Project direct costs: $179,765; Project total costs: $285,827
Role: Co-Investigator

8. "Mechanisms Linking Alcohol Use and Smoking Relapse Risk"
Principal Investigator: Christopher Kahler, Ph.D.
Grant type/number: R01 AA016978-03
Funding agency: National Institute on Drug Abuse
Period: April 2008 – December 2012
Project direct costs: $1,221,901; Project total costs: $1,941,922
Role: Co-Investigator

9. "Varenicline and Motivational Advice for Smokers with SUD"
Principle Investigator: Damaris Rohsenow, Ph.D.
Grant type/number: R01 DA024652-03
Funding agency: National Institute on Drug Abuse
Period: June 2008 – March 2013
Project direct costs: $2,241,138; Project total costs: $3,506,761
Role: Co-Principal Investigator

10. "Contingent Vouchers for Smoking in Substance Abusers as Adjunct to Nicotine Patch"
Principal Investigator: Damaris Rohsenow, Ph.D.
Grant type/number: R01 DA023995-02
Funding agency: National Institute on Drug Abuse
Period: July 2008 – May 2013
Project direct costs: $2,252,702; Project total costs: $3,511,976
Role: Co-Investigator

11. "Mechanisms Linking Anhedonia and Tobacco Addiction"
Principal Investigator: Adam Leventhal, Ph.D.
Grant type/number: R01 DA026831-01
Funding agency: National Institute on Drug Abuse
Period: August 2009 – May 2012
Project direct costs: $750,000; Project total costs: $1,217,709
Role: Consultant

12. "Examining a Unique Pharmacotherapy Intervention for Heavy Drinking Alcohol Dependent Individuals who Smoke"
Principal Investigator: Lorenzo Leggio, M.D., M.Sc.
Funding agency: Alcoholic Beverage Medical Research Foundation (ABMRF)
Period: January 2010 – December 2012
Project direct costs: $100,000
Role: Significant Contributor

13. "Effects of Baclofen on Alcohol Cue-Elicited Urges to Drink and Smoke"
Principal Investigator: Lorenzo Leggio, M.D., M.Sc.
Grant type/number: R03 AA20169-01
Funding agency: National Institute on Alcohol Abuse and Alcoholism
Period: September 2010 – August 2012
Project total costs: $40,500
Role: Significant Contributor

Teaching Experience

T-32 NIAAA/NIDA Postdoctoral Fellowship Seminars, Brown University CAAS "How to give an effective presentation" (2003), "Responding to pink sheets" (2001-2010), "Neurobiology Seminar Series: Behavioral pharmacology of opiates, cocaine, nicotine, and everything else" (2002-2005), "Neurobiology Seminar Series: Pharmacotherapy for dependence on nicotine, cocaine or opiates" (2003-2005), "Contingency management interventions" (2002-2004), "Studying smokers with schizophrenia in the human behavioral pharmacology laboratory" (2003), "Tips for IRB success" (2004-2005), Internal reviewer of post-doctoral fellow grant applications (2003-2005)

"Neurobiology and psychopharmacology of stimulants, nicotine and cross-addictions." (Feb 2003, Feb 2004, Feb 2005, Feb 2006). Seminar for course entitled Alcohol Use and Misuse.
"Biological and behavioral effects of nicotine" (Feb 2007). Seminar for course entitled Tobacco, Smoking, and the Evil Empire.
"Neurobiology and psychopharmacology of alcohol's effects" (Feb 2008, Feb 2010). Seminar for course entitled Alcohol Use and Misuse.

View My Full Publication List in pdf format